Skip to content

Opko Health OPK Debt-to-equity

Debt-to-equity at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
0.9×-0.1×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
0.0×
HRO
HarrowHROW
10.7×+2.6×
Precigen logo
PrecigenPGEN
4.9×
Immunome logo
ImmunomeIMNM
0.0×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
3.7×

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Current ratio3.6×+1.1×

Where this comes from

Calculated from Opko Health’s reported figures.

Based on the most recent quarter.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's debt-to-equity?
Opko Health (OPK) reported debt-to-equity of 0× in Q1 2026.
How has Opko Health's debt-to-equity changed year-over-year?
Opko Health's debt-to-equity increased by 4.3% year-over-year, from 0× to 0×.
What is the long-term trend for Opko Health's debt-to-equity?
Over 5 years (2020 to 2025), Opko Health's debt-to-equity has grown at a 7.4% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.